Literature DB >> 18174176

Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts.

Jeong-Ah Kang1, Ying Zhou, Tahlia L Weis, Hui Liu, Jodie Ulaszek, Nilesh Satgurunathan, Li Zhou, Koen van Besien, John Crispino, Amit Verma, Philip S Low, Amittha Wickrema.   

Abstract

Erythropoietin and stem cell factor are the key cytokines that regulate early stages of erythroid differentiation. However, it remains undetermined whether additional cytokines also play a role in the differentiation program. Here, we report that osteopontin (OPN) is highly expressed and secreted by erythroblasts during differentiation. We also demonstrate that OPN-deficient human and mouse erythroblasts exhibit defects in F-actin filaments, and addition of exogenous OPN to OPN-deficient erythroblasts restored the F-actin filaments in these cells. Furthermore, our studies demonstrate that OPN contributes to erythroblast proliferation. OPN knock-out male mice exhibit lower hematocrit and hemoglobin levels compared with their wild-type counterparts. We also show that OPN mediates phosphorylation or activation of multiple proteins including Rac-1 GTPase and the actin-binding protein, adducin, in human erythroblasts. In addition, we show that the OPN effects include regulation of intracellular calcium in human erythroblasts. Finally, we demonstrate that human erythroblasts express CD44 and integrins beta1 and alpha4, three known receptors for OPN, and that the integrin beta1 receptor is involved in transmitting the proliferative signal. Together these results provide evidence for signal transduction by OPN and contribution to multiple functions during the erythroid differentiation program in human and mouse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174176      PMCID: PMC3385928          DOI: 10.1074/jbc.M706712200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 2.  Regulating the actin cytoskeleton during vesicular transport.

Authors:  Mark Stamnes
Journal:  Curr Opin Cell Biol       Date:  2002-08       Impact factor: 8.382

3.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

Review 4.  New insights into erythropoiesis.

Authors:  Mark J Koury; Stephen T Sawyer; Stephen J Brandt
Journal:  Curr Opin Hematol       Date:  2002-03       Impact factor: 3.284

5.  The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Y H Lin; H F Yang-Yen
Journal:  J Biol Chem       Date:  2001-10-05       Impact factor: 5.157

6.  Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.

Authors:  S Razzouk; J C Brunn; C Qin; C E Tye; H A Goldberg; W T Butler
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

Review 7.  Role of osteopontin in cellular signaling and toxicant injury.

Authors:  D T Denhardt; C M Giachelli; S R Rittling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

8.  Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway.

Authors:  Ayako Arai; Eiichiro Kanda; Osamu Miura
Journal:  Oncogene       Date:  2002-04-18       Impact factor: 9.867

9.  Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice.

Authors:  Craig L Duvall; W Robert Taylor; Daiana Weiss; Abigail M Wojtowicz; Robert E Guldberg
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

10.  Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells.

Authors:  Shahab Uddin; Jeong Ah-Kang; Jodie Ulaszek; Dolores Mahmud; Amittha Wickrema
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

View more
  23 in total

1.  Vesicle trafficking plays a novel role in erythroblast enucleation.

Authors:  Ganesan Keerthivasan; Sara Small; Hui Liu; Amittha Wickrema; John D Crispino
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

2.  Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.

Authors:  Swarna Mehrotra; Bhumika Sharma; Sonali Joshi; Barbara Kroczynska; Beata Majchrzak; Brady L Stein; Brandon McMahon; Jessica K Altman; Jonathan D Licht; Darren P Baker; Elizabeth A Eklund; Amittha Wickrema; Amit Verma; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

3.  High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis.

Authors:  Yiting Yu; Yongkai Mo; David Ebenezer; Sanchari Bhattacharyya; Hui Liu; Sriram Sundaravel; Orsolya Giricz; Sandeep Wontakal; Jessy Cartier; Bennett Caces; Andrew Artz; Sangeeta Nischal; Tushar Bhagat; Kathleen Bathon; Shahina Maqbool; Oleg Gligich; Masako Suzuki; Ulrich Steidl; Lucy Godley; Art Skoultchi; John Greally; Amittha Wickrema; Amit Verma
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

4.  HIF-1 directly induces TET3 expression to enhance 5-hmC density and induce erythroid gene expression in hypoxia.

Authors:  John Z Cao; Hui Liu; Amittha Wickrema; Lucy A Godley
Journal:  Blood Adv       Date:  2020-07-14

5.  Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liver.

Authors:  Zhenhua Sui; Roberta B Nowak; Andrea Bacconi; Nancy E Kim; Hui Liu; Jie Li; Amittha Wickrema; Xiu-li An; Velia M Fowler
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

Review 6.  Malaria, erythrocytic infection, and anemia.

Authors:  Kasturi Haldar; Narla Mohandas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.

Authors:  Sriram Sundaravel; Ryan Duggan; Tushar Bhagat; David L Ebenezer; Hui Liu; Yiting Yu; Matthias Bartenstein; Madhu Unnikrishnan; Subhradip Karmakar; Ting-Chun Liu; Ingrid Torregroza; Thomas Quenon; John Anastasi; Kathy L McGraw; Andrea Pellagatti; Jacqueline Boultwood; Vijay Yajnik; Andrew Artz; Michelle M Le Beau; Ulrich Steidl; Alan F List; Todd Evans; Amit Verma; Amittha Wickrema
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

8.  Stage-specific susceptibility of human erythroblasts to Plasmodium falciparum malaria infection.

Authors:  Pamela A Tamez; Hui Liu; Sebastian Fernandez-Pol; Kasturi Haldar; Amittha Wickrema
Journal:  Blood       Date:  2009-08-25       Impact factor: 22.113

Review 9.  Malaria modeling: In vitro stem cells vs in vivo models.

Authors:  Florian Noulin
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

10.  Osteopontin and the C-terminal peptide of thrombospondin-4 compete for CD44 binding and have opposite effects on CD133+ cell colony formation.

Authors:  Gulzhakhan Sadvakassova; Monica C Dobocan; Luis F Congote
Journal:  BMC Res Notes       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.